Evidence map›Paper›PMID 36437406›Full record

ArticleCommunications biology2022

CLK1/CLK2-driven signalling at the Leishmania kinetochore is captured by spatially referenced proximity phosphoproteomics.

Vincent Geoghegan, Juliana B T Carnielli, Nathaniel G Jones, Manuel Saldivia, Sergios Antoniou, Charlotte Hughes, Rachel Neish, Adam Dowle, Jeremy C Mottram

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Identification of a conserved gene family with an essential role inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. CRISPR-Cas9 precision editing of kinetochore protein phosphosite codons inFrontiers in cellular and infection microbiology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Vincent Geoghegan *York Biomedical Research Institute and Department of Biology, University of York, Wentworth Way, Heslington, York, YO10 5DD, UK.
Juliana B T Carnielli *York Biomedical Research Institute and Department of Biology, University of York, Wentworth Way, Heslington, York, YO10 5DD, UK.ORCID 0000-0003-2116-6379
Nathaniel G JonesYork Biomedical Research Institute and Department of Biology, University of York, Wentworth Way, Heslington, York, YO10 5DD, UK.ORCID 0000-0001-7328-4487
Manuel SaldiviaNovartis Institute for Tropical Diseases, Emeryville, CA, USA.
Sergios AntoniouYork Biomedical Research Institute and Department of Biology, University of York, Wentworth Way, Heslington, York, YO10 5DD, UK.ORCID 0000-0001-7545-1162
Charlotte HughesYork Biomedical Research Institute and Department of Biology, University of York, Wentworth Way, Heslington, York, YO10 5DD, UK.
Rachel NeishYork Biomedical Research Institute and Department of Biology, University of York, Wentworth Way, Heslington, York, YO10 5DD, UK.
Adam DowleBioscience Technology Facility, Department of Biology, University of York, York, YO10 5DD, UK.ORCID 0000-0002-6501-5444
Jeremy C MottramYork Biomedical Research Institute and Department of Biology, University of York, Wentworth Way, Heslington, York, YO10 5DD, UK. jeremy.mottram@york.ac.uk.ORCID 0000-0001-5574-3766
University of York · GBNovartis (United States) · US

Funding

Medical Research Council MR/P027989/1Wellcome Trust 200807/Z/16/Z
6 · The paper itself

Abstract

Kinetochores in the parasite Leishmania and related kinetoplastids appear to be unique amongst eukaryotes and contain protein kinases as core components. Using the kinetochore kinases KKT2, KKT3 and CLK2 as baits, we developed a BirA* proximity biotinylation methodology optimised for sensitivity, XL-BioID, to investigate the composition and function of the Leishmania kinetochore. We could detect many of the predicted components and also discovered two novel kinetochore proteins, KKT24 and KKT26. Using KKT3 tagged with a fast-acting promiscuous biotin ligase variant, we took proximity biotinylation snapshots of the kinetochore in synchronised parasites. To quantify proximal phosphosites at the kinetochore as the parasite progressed through the cell cycle, we further developed a spatially referenced proximity phosphoproteomics approach. This revealed a group of phosphosites at the kinetochore that were highly dynamic during kinetochore assembly. We show that the kinase inhibitor AB1 targets CLK1/CLK2 (KKT10/KKT19) in Leishmania leading to defective cytokinesis. Using AB1 to uncover CLK1/CLK2 driven signalling pathways important for kinetochore function at G2/M, we found a set of 16 inhibitor responsive kinetochore-proximal phosphosites. Our results exploit new proximity labelling approaches to provide a direct analysis of the Leishmania kinetochore, which is emerging as a promising drug target.

Indexed as

KinetochoresLeishmaniaBiotinylationProtein Kinase InhibitorsProtein Kinase Inhibitors

Identifiers

PMID36437406
PMCPMC9701682
OpenAlexW4310267006

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.